GH — Guardant Health Income Statement
0.000.00%
- $8.16bn
- $8.65bn
- $739.02m
- 43
- 23
- 87
- 49
Annual income statement for Guardant Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 287 | 374 | 450 | 564 | 739 |
| Cost of Revenue | |||||
| Gross Profit | 194 | 251 | 294 | 337 | 449 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 542 | 760 | 999 | 1,165 | 1,183 |
| Operating Profit | -255 | -386 | -550 | -601 | -444 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -246 | -384 | -653 | -479 | -435 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -246 | -385 | -655 | -479 | -436 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -254 | -406 | -655 | -479 | -436 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -254 | -406 | -655 | -479 | -436 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.54 | -4.16 | -6.37 | -4.07 | -3.56 |